Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 5,000.00
0.00 (0.00%)
At close: Jan 2, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 34.49 billion as of January 8, 2026. Its market cap has increased by 11.70% in one year.
Market Cap
34.49B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,000.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 34.49B, a decrease of -58.35%. That is a compound annual growth rate of -22.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 34.49B | 2.82% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 903.85T |
| SK hynix | 480.56T |
| LG Energy Solution | 86.93T |
| Samsung Biologics | 79.30T |
| Hyundai Motor Company | 74.03T |
| SK Square | 54.95T |
| HD Hyundai Heavy Industries | 53.85T |
| Doosan Enerbility | 53.29T |